COVID-19 Vaccine Booster Trial Blinded Elixir from Japan
Blinded liquid elixir placebo for oral intake in Phase IV COVID-19 booster trials, in 10ml sachets mimicking vaccine adjuvant taste profile. Falls under HTS 3006.93.60.00 as double-blinded clinical trial material in measured oral doses.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Provide emergency use authorization or IND linked to public health emergency trials for expedited clearance
• Label with trial phase and sponsor to distinguish from waste pharmaceuticals under 3006(k)
• Test for alcohol content if any, to avoid Chapter 22 reclassification